Skip to main content
SpringerLink
Log in
Book cover

Spermatogenesis — Fertilization — Contraception pp 477–501Cite as

Hormonal Male Contraception: A Real Chance?

  • Conference paper

Part of the book series: Schering Foundation Workshop ((SCHERING FOUND,volume 4))

Abstract

Health and prosperity of individuals and communities alike are linked to population growth. European and North American countries are now in the late phase of a demographic transition and have achieved largely stable populations where birth rates equal or only slightly exceed death rates. This balance depends to a paramount extent on the availability of methods for birth control. This is illustrated by representative opinion polls performed in Germany 1958 and in 1989 (Allensbach 1958 and 1989). At both time points the ideal family size, in the opinion of the majority of couples of reproductive age, comprised two children.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aitken RJ, Paterson M, Thillai Koothan P (1992) Risks and benefits of immunological contraception. In: Nieschlag E, Habenicht OF (eds) Spermatogenesis — fertilization — contraception: Molecular, cellular and endocrine events in male reproduction. Springer Verlag, Heidelberg

    Google Scholar 

  • Akhtar FB, Marshall GR, Wickings E, Nieschlag E (1983) Reversible induction of azoospermia in rhesus monkeys by constant infusion of a GnRH agonist using osmotic minipumps. J Clin Endocrinol Metab 56: 534 – 540

    Article  PubMed  CAS  Google Scholar 

  • Allensbach Umfragen No. 1020 (1958) and No. 5053 (1989)

    Google Scholar 

  • Alvarez-Sanchez F, Faundes A, Brache V, Leon P (1977) Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate. Contraception 15: 635 – 648

    Article  PubMed  CAS  Google Scholar 

  • Bardin CW, Swerdloff RS, Santen RI (1991) Androgens: risks and benefits. J Clin Endocrinol Metab 73: 4 – 7

    Article  PubMed  CAS  Google Scholar 

  • Behre HM, Oberpenning F, Nieschlag E (1990) Comparative pharmacokinetics of androgen preparations: application of computer analysis and simulation. In: Nieschlag E, Behre HM (eds) Testosterone — Action, deficiency, substitution. Springer Verlag, Heidelberg pp 115–135

    Chapter  Google Scholar 

  • Behre HM, Klein B, Steinmeyer E, Nieschlag E (1992a) Effective suppression of luteinizing hormone and testosterone by single doses of the new GnRH antagonist cetrorelix (SB-75) in normal men. J Clin Endocr Metab (in press)

    Google Scholar 

  • Behre HM, Nashan D, Hubert W, Nieschlag E (1992b) Depot gonadotropinreleasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab 74: 84–90

    Article  PubMed  CAS  Google Scholar 

  • Behre HM, Nieschlag E (1992c) Testosterone buciclate (20-Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamies of the new long-acting androgen ester. J Clin Endocrinol Metab (in press)

    Google Scholar 

  • Bergquist C, Nillius SG, Bergh T, Skering G, Wide G (1979) Inhibitory effects on gonadotropin secretion and gonadal function in men during chronic treatment with a potent stimulatory luteinizing hormone-releasing hormone analogue. Acta Endocrinol 91: 610–618

    Google Scholar 

  • Bhasin S, Heber D, Steiner BS, Handelsmann DJ, Swerdloff RS (1985) Hormonal effects of gonadotropin-releasing-hormone (GnRH) agonist in the human male. III. Effects of long-term combined treatment with GnRH agonist and androgen. J Clin Endocrinol Metab 60: 998-1003

    Google Scholar 

  • Bhasin S, Yuan QX, Steiner BS, Swerdloff RS (1987) Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men. Effects of longterm treatment with GnRH agonist infusion and androgens. J Clin Endocrinol Metab 65: 568-574

    Google Scholar 

  • Bhasin S, Swerdloff RS, Steiner B et al. (1992) A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. J Clin Endocrinol Metab 74: 75 – 83

    Article  PubMed  CAS  Google Scholar 

  • Bouchard P, Garcia E (1987) Influence of testosterone substitution on sperm suppression by LHRH agonists. Horm Res 28: 175 – 180

    Article  PubMed  CAS  Google Scholar 

  • Bremner WJ, Bagatell CJ, Steiner RA (1991) Goandotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive. J Clin Endocrinol Metab 73: 465 – 469

    Article  PubMed  CAS  Google Scholar 

  • Burris AS, Ewing LL, Sherins RJ (1988) Initial trial of slow release testosterone microspheres in hypogonadal men. Fertil Steril 50: 493 – 497

    PubMed  CAS  Google Scholar 

  • Clayton RN, Channabasavaiah K, Stewart JM, Catt KJ (1982) Hypothalamic regulation of pituitary gonadotropin-releasing hormone receptors: effects of hypothalamic lesions and a gonadotropin-releasing hormone antagonist. Endocrinology 110: 1108 – 1115

    Article  PubMed  CAS  Google Scholar 

  • Cooper TG (1992) The epididymis as a site of contraceptive attack. In: Nieschlag E, Habenicht OF (eds) Spermatogenesis — fertilization — contraception: Molecular, cellular and endocrine events in male reproduction. Springer Verlag, Heidelberg

    Google Scholar 

  • Delanoe D, Fougevrollas B, Meyer L, Thonneau P (1984) Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet 1: 276

    Article  PubMed  CAS  Google Scholar 

  • Diczfalusy E (1987) Has family planning a future? In: Diczfalusy E, Bydgemann M (eds) Fertility regulation today and tomorrow. Raven Press, New York pp 3 – 9

    Google Scholar 

  • Doelle GC, Alexander AN, Evans RM, Linde R, Rivier J, Vale W, Rabin D (1983) Combined treatment with an LHRH agonist and testosterone in man. J Androl 4: 298 – 302

    PubMed  CAS  Google Scholar 

  • Fogh M, Corcker CS, Hunter WM, McLean H, Philip J, Schon G, Skakkebaek NE (1979) The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men. Acta Endocrinol 91: 545

    PubMed  CAS  Google Scholar 

  • Frick J, Aulitzky W (1986) Effects of a potent LHRH agonist on the pituitary-go- nadal axis with and without testosterone substitution. Urol Res 14: 261 – 264

    Article  PubMed  CAS  Google Scholar 

  • Friedl KE, Hannan CJ, Jones RE, Plymate SR (1990) High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Mebatolism 39: 69 – 74

    CAS  Google Scholar 

  • Gaitan D, Lindner J, Farley MG, Monroe SE, Pavlou SN (1991) Antireproductive properties of a novel GnRH antagonist in men. 73rd Ann Meeting Endocr Soc, Washington, abstr 1156

    Google Scholar 

  • Giwercman A, Skakkebaek NE (1986) The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review. Int J Androl 9: 28-52

    Google Scholar 

  • Gooren LJG, Polderman KH (1990) Safety aspects of androgen therapy. In: Nieschlag E, Behre HM (eds) Testosterone–Action, deficiency, substitution. Springer Verlag, Heidelberg, pp 182 – 203

    Chapter  Google Scholar 

  • Hamilton DW, Waites GMH (eds) (1990) Cellular and molecular events in spermiogenesis. Cambridge University Press

    Google Scholar 

  • Handelsman, DJ, Conway AJ, Boylan LM (1990) Pharmacokinetics and pharmacodynamics of testosterone pellets in man. J. Clin Endocrinol Metab 71: 216 – 222

    Article  PubMed  CAS  Google Scholar 

  • Heber D, Dodson R, Swerdloff RS, Channabasavaiah K, Stewart JM (1982) Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: mechanism of action. Science 216: 420 – 421

    Article  PubMed  CAS  Google Scholar 

  • Hedman M, Gottlieb C, Svanborg K, Bydgeman M, de la Torre B (1988) Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men. Int J Androl 11: 265 – 276

    Article  PubMed  CAS  Google Scholar 

  • Karten MI, Hoeger CA, Hook WA, Lindberg MC, Naqvi RH (1990) The development of safer GnRH antagonists: strategy and status. In: Bouchard P, Haour F, Franchimont P, Schatz B (eds) Recent progress on GnRH and gonadal peptides, Elsevier, Paris, pp 147 – 158

    Google Scholar 

  • Knuth UA, Behre HM, Belkien L, Bents H, Nieschlag E (1985) Clinical trial of 19-nortestosterone of male fertility regulation. Fertil Steril 44: 814 – 821

    PubMed  CAS  Google Scholar 

  • Knuth UA, Maniera H, Nieschlag E (1989a) Anabolic steroids and semen parameters in bodybuilders. Fertil Steril 52: 1041 – 1047

    Google Scholar 

  • Knuth UA, Yeung CH, Nieschlag E (1989b) Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyproges-terone-acetate ( Clinovir) for male contraception. Fertil Steril 51: 10111018

    Google Scholar 

  • König U (1991) Revolution bei der Verhütung: Jetzt sind die Manner dran. Stern 24/91: 28 – 34

    Google Scholar 

  • Leonard JM, Paulsen CA (1978) The use of androgens plus synthetic steroids as a reversible means of regulating male fertility. In: Fabbrini A, Steinberger E (eds) Recent progress in andrology. Academic Press, New York p 271

    Google Scholar 

  • Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D (1981) Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men. N Engl J Med 305: 663–667

    Article  PubMed  CAS  Google Scholar 

  • Marshall GR, Akhtar FB, Weinbauer GF, Nieschlag E (1986) Gonadotrophinreleasing hormone ( GnRH) overcomes GnRH antagonist-induced suppression of LH secretion in primates. J Endocrinol 110: 145–150

    Google Scholar 

  • Meyer WJ, Walker PA, Emory LE, Smith ER (1985) Physical, metabolic and hormonal effects on men of long-term therapy with medroxyprogesterone acetate. Fertil Steril 43: 102 – 109

    PubMed  CAS  Google Scholar 

  • Michel E, Bents H, Akthar FB, Honig! W, Knuth UA, Sandow J, Nieschlag E (1985) Failure of high-dose sustained-release luteinizing hormone agonist (buserelin) plus oral testosterone to suppress male fertility. Clin Endocrinol 23: 663–675

    Article  CAS  Google Scholar 

  • Moeloek N (1990) Combination of testosterone enanthate + DMPA and 19nortestosterone-hexyloxyphenylpropionate + DMPA for male contraception (abstract). 16th Conference on Science and Technology of Thailand

    Google Scholar 

  • Moltz L, Römmler A, Post K, Schwartz U, Hammerstein J (1980) Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in man. Contraception 21: 393

    Article  PubMed  CAS  Google Scholar 

  • Moudgal NR, Ravindranath N, Murthy GS, Dighe RR, Aravindan GR (1991) On the development of a male contraceptive vaccine. In: Moudgal NR, Yoshinaga K, Rao AJ, Adiga RR (eds) Perspectives in primate reproductive biology. Wiley Eastern, New Dehli, pp 297 – 306

    Google Scholar 

  • Nieschlag E (1986) Reasons for abandoning immunization against FSH as an approach to male fertility regulation. In: Zatuchni GI, Goldsmith A, Sciarra JJ, Spieler J (eds) Male contraception: advances and future prospects. Harper and Row, Philadelphia, pp 395–400

    Google Scholar 

  • Nieschlag E (1987) Vasektomie–pro und contra. Dtsch Med Wochenschr 112: 1107–1109

    Article  PubMed  CAS  Google Scholar 

  • Nieschlag E, Behre HM (1990) Pharmacology and clinical use of testosterone. In: Nieschlag E, Behre HM (eds.) Testosterone–Action, deficiency, substitution. Springer Verlag, Heidelberg, pp 92–114

    Chapter  Google Scholar 

  • Nieschlag E, Hoogen H, Bölk M, Schuster H, Wickings EJ (1978) Clinical trial with testosterone undecanoate for male fertility control. Contraception 18: 607–614

    Article  PubMed  CAS  Google Scholar 

  • Nieschlag E, Waites GMH, Paulsen CA, Handelsman DJ (1990) Safety of testosterone enanthate/Tumorigenic effect of testosterone ( Letter to the Editor ). Lancet 336: 1517-1518

    Google Scholar 

  • Pangkahila W (1991) Reversible azoospermia induced by an androgen-proges- tin combination regimen in Indonesian men. Int J Androl 44: 248–256

    Article  Google Scholar 

  • Patanelli DJ (ed) (1978) Hormonal control of male fertility. Bethesda US Department of Health, Education and Welfare. National Institutes of Health. Publication no. (NIH) 78: 1097

    Google Scholar 

  • Paulsen CA, Bremner WJ, Leonard JM (1982) Male contraception: Clinical trials. In: Mishell DR (ed) Advances in fertility research. Raven Press, New York, pp 157–170

    Google Scholar 

  • Pavlou SN, Debold CR, Island DP, Wakefield G, Rivier J, Vale W, Rabin D (1986) Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men. J Clin Endocrinol Metab 63: 303–308

    Article  PubMed  CAS  Google Scholar 

  • Pavlou SN, Brewer K, Farley MG, Lindner, J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn M, Herbert CM (1991) Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. J Clin Endocrinol Metab 73: 1360–1369

    Article  PubMed  CAS  Google Scholar 

  • Quian SZ (1987) Tripterygidium wilfordii, a new lead in male fertility regulation. In: Diczfalusy E, Bydgeman M (eds) Fertility regulation today and tomorrow. Raven Press, New York pp 217–232

    Google Scholar 

  • Rabin D, Evans RM, Alexander AN, Doelle GC, Rivier J, Vale W, Liddle G (1984) Heterogeneity of sperm density profiles following 20-week therapy with high-dose LHRH analog plus testosterone. J Androl 5: 176–180

    PubMed  CAS  Google Scholar 

  • Schearer SB, Alvarze-Sanchez F, Anselmo G, Brenner P, Coutinho E, LathenFaundes A, Frick J, Heinild B, Johansson EDB (1978) Hormonal contraception for men. Int J Androl Suppl 2: 680–712

    Article  Google Scholar 

  • Schröder FF (1990) Androgens and carcinoma of the prostate. In: Nieschlag E, Behre HM (eds) Testosterone–Action, deficiency, substitution. Springer Verlag, Heidelberg, pp 245–260

    Chapter  Google Scholar 

  • Schürmeyer Th, Knuth UA, Belkien L, Nieschlag E (1984a) Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet 1: 417420

    Google Scholar 

  • Schürmeyer Th, Knuth UA, Freischem CW, Sandow J, Akthar FB, Nieschlag E (1984b) Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol Metab 59: 1–6

    Article  Google Scholar 

  • Segal S (ed) (1985) Gossypol–a potential contraceptive for men. Plenum Press, New York

    Google Scholar 

  • Soufir JC, Jouannet P, Marson J, Soumah A (1983) Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Acta Endocrinol 102: 625

    PubMed  CAS  Google Scholar 

  • Srinath BR, Wickings EJ, Nieschlag E (1983) Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2 year study in male rhesus monkeys. Fertil Steril40: 110–117

    Google Scholar 

  • Tom L, Salameh W, Bhasin S, Steiner B, Peterson M, Swerdloff RS (1991) Male contraception: Achievement of reversible azoospermia by combined gonadotropin releasing hormone antagonist and testosterone treatment. 73rd Ann Meeting Endocr Soc, Washington, abstr 1154

    Google Scholar 

  • Turner JW, Kirkpatrick JF (1982) Androgens, behaviour and fertility control in feral stallions. J Reprod Fertil 32: 79

    Google Scholar 

  • Wallace EM, Wu FCW (1990) Effect of depot medroxyprogesterone acetate and testosterone enanthate on serum lipoproteins in man Contraception 41: 63–71

    CAS  Google Scholar 

  • Wang C, Yeung KK (1980) Use of a low dosage oral cyproterone acetate as a male contraceptive. Contraception 21: 245

    Article  PubMed  CAS  Google Scholar 

  • Weinbauer GF, Nieschlag E (1985) Regulation of primate testicular function by GnRH analogues. Med Biol 63: 210–217

    CAS  Google Scholar 

  • Weinbauer GF, Nieschlag E (1990) The role of testosterone in spermatogenesis. In: Nieschlag E, Behre HM (eds) Testosterone–Action, deficiency, substitution. Springer Verlag, Heidelberg pp 23–50

    Chapter  Google Scholar 

  • Weinbauer GF, Nieschlag E (1992) Peptide and steroid regulation of spermatogenesis in primates. In: Robaire, B. (ed) The male germ cell: spermatogonium to fertilization. New York Academy of Sciences Annals vol 637, pp 107–121

    Google Scholar 

  • Weinbauer GF, Marshall GR, Nieschlag E (1986) New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months. Acta Endocrinol 113: 128–132

    PubMed  CAS  Google Scholar 

  • Weinbauer GF, Respondek M, Themann H, Nieschlag E (1987) Reversibility of long-term effects of GnRH agonist administration on testicular histology and sperm production in the nonhuman primate. J Androl 8: 319–329

    PubMed  CAS  Google Scholar 

  • Weinbauer GF, Göckeler E, Nieschlag E (1988) Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone (GnRH) antagonist-treated non-human primate ( Macaca fascicularis ). J Clin Endocrinol Metab 67: 284-290

    Google Scholar 

  • Weinbauer GF, Khurshid S, Fingscheidt U, Nieschlag E (1989) Sustained inhibition of sperm production and inhibin secretion induced by a gonadotrophin-releasing hormone antagonist and delayed testosterone substitution in non-human primates ( Macacaa fascicularis ). J Endocrinol 123: 303-310

    Google Scholar 

  • Weinbauer GF, Behre HM, Nieschlag E (1990) Contraceptive studies with GnRH analogs in men and non-human primates. In: Bouchard P, Haour F, Franchimont P, Schatz B (eds) Recent progress on GnRH and gonadal peptides, Elsevier, Paris, pp 181–194

    Google Scholar 

  • Weinbauer GF, Behre HM, Fingscheidt U, Nieschlag E (1991) Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate ( Macaca fascicularis ). Endocrinology 129: 1831-1839

    Google Scholar 

  • WHO (1972-1983) Special Programme of Research Development and Research Training in Human Reproduction: Annual Reports. Geneva

    Google Scholar 

  • WHO Task Force on Methods for the Regulation of Male Fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336: 955–959

    Article  Google Scholar 

  • WHO (1991) Special Programme of Research, Development and Research Training in Human Reproduction. Annual Technical Report 1990. Geneva pp 74–75

    Google Scholar 

  • Wu FCW, Aitken RJ (1989) Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception. Fertil Steril 51: 691–698

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Eberhard Nieschlag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hermann M. Behre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerhard F. Weinbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Reproductive Medicine of the University, Steinfurter Str. 107, 4400, Münster, Germany

    Eberhard Nieschlag

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Nieschlag, E., Behre, H.M., Weinbauer, G.F. (1992). Hormonal Male Contraception: A Real Chance?. In: Nieschlag, E., Habenicht, UF. (eds) Spermatogenesis — Fertilization — Contraception. Schering Foundation Workshop, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02815-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02815-5_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-02817-9

  • Online ISBN: 978-3-662-02815-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation